Ctrl K
LIN trades 17.4% below Wall Street's consensus target of $566.25.
Last 12 months price action with 12-month analyst target path
The base valuation assumes LIN achieves its forward estimates and maintains a stable P/E multiple of 27.0x. This scenario reflects the blended consensus of 28 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 4, 2026, Linde plc (LIN) has a Wall Street consensus price target of $566.25, based on estimates from 28 covering analysts. With the stock currently trading at $482.19, this represents a potential upside of +17.4%. The company has a market capitalization of $223.06B.
Analyst price targets range from a low of $525.00 to a high of $612.00, representing a 15% spread in expectations. The median target of $569.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 25 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, LIN trades at a trailing P/E of 33.0x and forward P/E of 27.0x. The forward PEG ratio of 1.06 indicates reasonable valuation for growth. Analysts expect EPS to grow +14.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $322.48, with bear and bull scenarios of $203.16 and $424.90 respectively. Model confidence stands at 57/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 APDAir Products and Chemicals, Inc. | $67.7B | $304.22 | $346.44 | +13.9% | Buy | 22.7x | 42 |
 ALBAlbemarle Corporation | $15.6B | $132.16 | $202.63 | +53.3% | Hold | 11.5x | 45 |
 ECLEcolab Inc. | $78.5B | $278.97 | $326.13 | +16.9% | Buy | 34.2x | 37 |
 PPGPPG Industries, Inc. | $24.6B | $110.75 | $130.00 | +17.4% | Buy | 14.0x | 38 |
 SHWThe Sherwin-Williams Company | $80.7B | $332.26 | $391.50 | +17.8% | Buy | 27.5x | 38 |
 PXP10, Inc. | $909M | $7.55 | $15.50 | +105.3% | Buy | 6.9x | 8 |
 AXTAAxalta Coating Systems Ltd. | $7.7B | $35.97 | $34.60 | -3.8% | Hold | 13.6x | 28 |
 CECelanese Corporation | $5.0B | $45.20 | $60.40 | +33.6% | Hold | 7.5x | 37 |
 EMNEastman Chemical Company | $8.1B | $70.77 | $81.00 | +14.5% | Buy | 11.1x | 35 |
 HUNHuntsman Corporation | $1.6B | $9.40 | $12.00 | +27.7% | Hold | — | 33 |
Quick answers to the most common questions about buying LIN stock.
Linde plc (LIN) has a consensus 12-month price target of $566.25, implying 17.4% upside from $482.19. The 28 analysts covering LIN see moderate appreciation potential.
LIN has a consensus rating of "Buy" based on 28 Wall Street analysts. The rating breakdown is predominantly bullish, with 25 Buy/Strong Buy ratings. The consensus 12-month price target of $566.25 implies 17.4% upside from current levels.
LIN trades at a forward P/E of 26.9671x, representing a moderate valuation. With analysts targeting $566.25 (17.4% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $612 for LIN, while the most conservative target is $525. The consensus of $566.25 represents the median expectation. Our quantitative valuation model projects a bull case target of $425 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
LIN is heavily covered by Wall Street, with 28 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 25 have Buy ratings, 3 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month LIN stock forecast based on 28 Wall Street analysts shows a consensus price target of $566.25, with estimates ranging from $525 (bear case) to $612 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $322, with bear/bull scenarios of $203/$425.
Our quantitative valuation model calculates LIN's fair value at $322 (base case), with a bear case of $203 and bull case of $425. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 57/100.
LIN trades at a forward P/E ratio of 27.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 33.0x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on LIN, with a "Buy" consensus rating and $566.25 price target (17.4% upside). 25 of 28 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
LIN analyst price targets range from $525 to $612, a 15% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $566.25 consensus represents the middle ground. Our model's $203-$425 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Bull/bear thesis, analyst target revisions, and earnings execution.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.